Ethan Roberts

Ethan Roberts

InvestorPlace Contributor

Ethan Roberts is a stock and real estate investor, and a financial writer. He has taught courses for more than a decade in the Jacksonville, Fla., area on investing for retirement and investing in residential real estate. Ethan is also a licensed real estate agent in the state of Florida and served as the real estate editor of a major newsletter, The Tycoon Report, for three years.

His articles on stocks, finance and real estate have also been featured on Reuters.com, Seeking Alpha, Market Greenhouse and many other financial Web sites. In 2010, he created Fast Profit Trades, a website primarily devoted to day trading and swing trading.

Follow him on Twitter: @FastProfitTrade.

Recent Articles

Why GameStop, U.S. Silica, and Ziopharm are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor

Poor December retail sales, a Fed warning on slower growth, and a copper meltdown spooks Wall Street, but Gamestop, U.S. Silica, and Ziopharm are three of today's best stocks.

Why Dunkin Brands, Pharmacyclics, and IHS are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor

A wild day on Wall Street saw the Dow give back 300 points gained early on, while Dunkin Brands, IHS, and Pharmacyclics are 3 of Today's Best Stocks.

Dollar Tree to Family Dollar: Enough Is Enough!

By Ethan Roberts, InvestorPlace Contributor

The pressure is on -- Dollar Tree's (DLTR) CEO has given Family Dollar (FDO) an ultimatum, which means sooner or later, we'll know if we have a merger.

Why Bristol-Myers, Lululemon, and Foundation Medicine Are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor

A decline in crude oil again sank the markets, but Bristol-Myers, Lululemon, and Foundation Medicine are 3 of Today's Best Stocks.

Why 3D Systems, Global Payments and BIND Therapeutics Are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor

The bulls are once more firmly in control of Wall Street, and 3D Systems, Global Payments, and BIND Therapeutics were three of Thursday's best stocks.

Load More